Biotech Startups
10,020 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
0 investors
Hallux Inc. develops Hallux Subungual Gel (HSG), a physician-administered terbinafine treatment applied directly to the nail bed to treat onychomycosis (fungal nail infection). The pharmaceutical product is being evaluated in clinical trials for use by podiatrists and dermatologists at the point-of-care.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Hapten Sciences develops early-stage pharmaceutical products focused on dermatological health, with its lead candidate PDC-APB in clinical development as a preventive immunotherapy for contact dermatitis caused by exposure to poisonous plants. The company targets healthcare providers and individuals affected by urushiol-related skin conditions.
0 investors
0 investors
0 investors
0 investors
0 investors
Harvest Connect operates a wellness ecosystem of plant-based medicine brands, including Graceleaf CBD/CBN blends, Aspen Tree natural wellness products, CBD Store & More retail locations, and EntheoTech Health, which researches natural and psychedelic compounds for treating Traumatic Brain Injury. It serves consumers seeking mental wellness and calm through cannabinoid products, with retail operations in the southeastern US and Washington DC.
0 investors
HavaH Therapeutics develops T+Ai, a subcutaneous extended-release pellet combining testosterone and anastrozole, aimed at preventing and treating hormone receptor positive breast cancer, including ductal carcinoma in situ (DCIS) and ER+ disease. The clinical-stage company targets the intra-mammary hormonal balance to slow tumor growth and reduce the need for surgery.
0 investors
0 investors
HCW Biologics is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics as first-in-class immunotherapies for autoimmune diseases, cancer, and senescence-associated dysplasia. It uses proprietary drug discovery platforms to create multi-specific cytokines, targeted immune checkpoint inhibitors, and immune-cell engagers, with lead candidates in commercial and clinical stages.
0 investors
HDL Therapeutics is a commercial-stage biotechnology company with an FDA-approved therapy that reduces coronary atheroma in a rare cardiovascular disease. The company develops therapies targeting cardiovascular, neurodegenerative, autoimmune, viral, and peripheral vascular diseases.
0 investors
Headlands Research operates a multinational clinical trial site network that recruits and retains diverse participant populations for medical research studies. The organization supports pharmaceutical sponsors and research sites in advancing innovative therapies through operational excellence and high-quality data collection across multiple therapeutic areas.
0 investors
0 investors
0 investors
0 investors
0 investors